$AMRN As previously mentioned the issue of mineral oil in placebo affecting statin absorption remains controversial in REDUCEIT httpstwitter.comAndyBiotechstatus1044226980944781314Â AHA18LDLC 10 stat sig increase from baseline in

$AMRN As previously mentioned, the issue of mineral oil in placebo affecting statin absorption remains controversial in REDUCE-IT https://twitter.com/AndyBiotech/status/1044226980944781314 … … #AHA18 LDL-C: +10% stat sig increase from baseline in

15:18 EST 10 Nov 2018 | Andy Biotech

$AMRN As previously mentioned, the issue of mineral oil in placebo affecting statin absorption remains controversial in REDUCE-IT https://twitter.com/AndyBiotech/status/1044226980944781314 … … #AHA18 LDL-C: +10% stat sig increase from baseline in placebo hsCRP: +30% stat sig increase from baseline in placebo pic.twitter.com/NnHdXLnucr

More From BioPortfolio on "$AMRN As previously mentioned, the issue of mineral oil in placebo affecting statin absorption remains controversial in REDUCE-IT https://twitter.com/AndyBiotech/status/1044226980944781314 … … #AHA18 LDL-C: +10% stat sig increase from baseline in"